financetom
Business
financetom
/
Business
/
CCC Intelligent Solutions to Consolidate 2 Executive Roles Following Planned Departures
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CCC Intelligent Solutions to Consolidate 2 Executive Roles Following Planned Departures
Oct 4, 2024 8:13 AM

10:55 AM EDT, 10/04/2024 (MT Newswires) -- CCC Intelligent Solutions Holdings ( CCCS ) said in a Friday filing it is consolidating the chief service delivery officer and chief commercial and customer success officer roles after the planned departure of Mary Jo Prigge and Michael Silva.

Prigge will retire as chief service delivery officer by Dec. 31 but is expected to continue as a part-time adviser to senior management, while Chief Commercial & Customer Success Officer Silva will leave the company by the end of 2024 due to the elimination of his role, the company said.

A search for a candidate to fill the consolidated role is underway, the company added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports
Nov 7, 2025
Nov 7 (Reuters) - Pfizer ( PFE ) has submitted a sweetened bid for obesity drug developer Metsera ( MTSR ), as its fight against rival Novo Nordisk escalates, Bloomberg News reported on Friday. The new offer improves upon Pfizer's ( PFE ) earlier proposal for $86.20 a share including milestone payments, the Bloomberg report said, citing people familiar with...
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports
Nov 7, 2025
(Reuters) -Pfizer ( PFE ) has submitted a sweetened bid for obesity drug developer Metsera ( MTSR ), as its fight against rival Novo Nordisk escalates, Bloomberg News reported on Friday. The new offer improves upon Pfizer's ( PFE ) earlier proposal for $86.20 a share including milestone payments, the Bloomberg report said, citing people familiar with the matter. Reuters...
EV maker Rivian gives CEO a Musk-style pay package worth up to $4.6 billion
EV maker Rivian gives CEO a Musk-style pay package worth up to $4.6 billion
Nov 7, 2025
(Reuters) -Electric pickup and SUV maker Rivian said on Friday it was giving its CEO a pay plan worth as much as $4.6 billion over the next decade, a deal similar to Tesla's record package for CEO Elon Musk, and linked to new profit targets and lower share price milestones than a previous deal. The move by the Rivian board...
Amazon takes low-cost e-commerce service global
Amazon takes low-cost e-commerce service global
Nov 7, 2025
(Reuters) -Amazon.com on Friday said it expanded its low-cost e-commerce service Amazon Bazaar, known as Haul in the U.S., to 14 additional markets, ramping up competition with Chinese rivals like Shein and PDD Holdings' Temu in the global race to sell ultra-cheap goods like $10 dresses and $5 accessories. Sweeping import tariffs imposed by U.S. President Donald Trump have dented...
Copyright 2023-2026 - www.financetom.com All Rights Reserved